Archive
1250 articles, sorted by publication time.
The grant is not cash, but six months of Claude usage credits; it may lower the computational barrier to rare genetic disease research, but cannot replace case quality, experimental validation, or clinical judgment.
The deal targets molecular residual disease monitoring after cancer treatment; the real test is whether expanded testing can be translated into a clinically validated, reimbursable long-term service that can change care decisions.
Experts voted 10–3 that RP1 has sufficient evidence for FDA review, but the interplay among a single-arm trial, intratumoral injection, and efficacy assessment will still shape its ultimate fate.
Researchers deleted CD33 from donor stem cells, allowing the rebuilt hematopoietic system to evade attacks from targeted drugs; an early trial involving 30 people demonstrated that transplantation was feasible, but its early termination and three transplant-related deaths limited interpretation of efficacy.
The Middle East’s first MONARCH robot-assisted bronchoscopy has been completed in Abu Dhabi, with the aim of shortening the path from imaging detection of a suspicious lung nodule to tissue diagnosis; however, publicly available comparative clinical data remain lacking on whether AI-enabled navigation can actually improve diagnostic yield.
Plant OpenCRISPR-1 not only cuts rice genes but can also substitute single bases and precisely rewrite sequences. Regenerated plants show that it does not function only in isolated cells, but off-target effects, traits, and field validation remain hurdles before breeding applications.
The research team combined protein structure models with evolutionary constraints to design RNA-guided nucleases whose sequences are far removed from their natural parents yet remain functional; the results span bacterial, plant, and human cells, but safety and delivery hurdles remain before medical or agricultural applications.
Researchers coated lipid nanoparticles with high-density mannose to deliver PTEN messenger RNA across the blood–brain barrier and target tumors; median survival in mice increased from 33 days to 49 days, but extensive validation is still needed before human trials.
The first participant has received the investigational vaccine and completed initial observation; this Phase 1 study will first clarify dosage and safety, then explore whether it can induce an antitumor immune response.
A study tracking high-risk carriers of familial ALS variants identified a plasma protein panel that can predict clinical conversion within six months to five years; the findings may help enroll participants in prevention trials but cannot yet be used for general population screening.
Pfizer’s GBS6 induced antibodies against six serotypes in pregnant women and transferred those antibodies to their infants; safety data support continued development, but the trial has not yet shown a reduction in neonatal infections.
Trained on 2.3 million whole-slide images and pathology reports to learn diagnostic language, PRISM2 matched specialized products in tests for prostate cancer, breast cancer, and breast lymph node metastasis without additional training for individual detection tasks. However, retrospective data, a single scanning source, and errors in report generation still limit its direct entry into clinical practice.